Abstract:Objective Thalassemia is a Mendelian‐inherited blood disorder with severe consequences, including disability and mortality, making it a significant public health concern. Therefore, there is an urgent need for precise diagnostic technologies. We introduce two innovative diagnostic techniques for thalassemia, SNPscan and CNVplex, designed to enhance molecular diagnostics of thalassemia. Methods The SNPscan and CNVplex assays utilize variations in PCR product length and fluorescence to identify multiple mutations. In the SNPscan method, we designed three probes per locus: two 5′ and one 3′, and incorporated allele identification link sequences into one of the 5′ probes to distinguish the alleles. The detection system was designed for 67 previously reported loci in the Chinese population for a specific genetic condition. CNVplex identifies deletion types by analyzing the specific positions of probes within the globin gene. This innovative approach enables the detection of six distinct deletional mutations, enhancing the precision of thalassemia diagnostics. We evaluated and refined the methodologies in a training cohort of 100 individuals with confirmed HBA and HBB genotypes. The validation cohort, consisting of 1647 thalassemia patients and 100 healthy controls, underwent a double‐blind study. Traditional diagnostic techniques served as the control methods. Results In the training set of 100 samples, 10 mutations (Hb QS, Hb CS, Hb Westmead, CD17, CD26, CD41‐42, IVS‐II‐654, ‐‐SEA, −α3.7 and −α4.2) were identified, consistent with those identified by traditional methods. The validation study showed that SNPscan/CNVplex offered superior molecular diagnostic capabilities for thalassemia, with 100% accuracy compared to 99.43% for traditional methods. Notably, the assay identified three previously undetected mutations in 10 cases, including two deletion mutations (Chinese Gγ(Aγδβ)0 del and SEA‐HPFH), and one non‐deletion mutation (Hb Q‐Thailand). Conclusions The SNPscan/CNVplex assay is a cost‐effective and user‐friendly tool for diagnosing thalassemia, demonstrating high accuracy and reliability, and showing great potential as a primary diagnostic method in clinical practice.

Combination of Multiplex Ligation-Dependent Probe Amplification with Gene Sequencing Technology for Detecting Gene Defect of Thalassemia

Analysis of the drawback of the combination of MLPA and gene sequencing technology in detecting thalassemia genes

AB034. Hemoglobinopathies in China and SEA: Rapid Targeted Deep Sequencing for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies

Detection of rare thalassemia mutations using long-read single-molecule real-time sequencing

Detection of alpha-thalassemia in China by using multiplex ligation-dependent probe amplification

Molecular spectrum and prevalence of thalassemia investigated by third-generation sequencing in the Dongguan region of Guangdong Province, Southern China

Molecular diagnosis of thalassemia compound heterozygotes in PUMCH from 2012 to 2015

Gene mutation analysis in 481 suspected patients with thalassemia in certain area

[Application of high-throughput sequencing technology in prenatal thalassemia screening in Zhuhai region].

Third-generation sequencing: A novel tool detects complex variants in the α-thalassemia gene

Third-generation sequencing identified a novel complex variant in a patient with rare alpha-thalassemia

SNPscan Combined With CNVplex as a High‐Performance Diagnostic Method for Thalassemia

Next-generation sequencing improves molecular epidemiological characterization of thalassemia in Chenzhou Region, P.R. China

[Application of Next Generation Sequencing to Screen the Neonatal Thalassemia Genes]

Analysis of rare thalassemia genetic variants based on third-generation sequencing

[Significance of the combined detection of routine blood test, serum iron and hemoglobin electrophoresis in screening thalassemia in non- high incidence area]

Accurate genotype diagnosis of Hong Kongαα thalassemia based on third-generation sequencing

The comprehensive analysis of thalassemia alleles (CATSA) based on single-molecule real-time technology (SMRT) is a more powerful strategy in the diagnosis of thalassemia caused by rare variants

Study on Prenatal Screening and Genotype Analysis of Α-Thalassemia

The Incidence of Thalassemia and the Analysis of Thalassemia-Associated Gene in Children in Guangzhou Region

Target-allele-specific probe single-base extension (TASP-SBE): a novel MALDI-TOF-MS strategy for multi-variants analysis and its application in simultaneous detection of α-/β-thalassemia mutations